???pagination.result.count???
???pagination.result.page???
1
Novel truncating mutations in CTNND1 cause a dominant craniofacial and cardiac syndrome. , Alharatani R., Hum Mol Genet. July 21, 2020; 29 (11): 1900-1921.
Shox2 is essential for the differentiation of cardiac pacemaker cells by repressing Nkx2-5. , Espinoza-Lewis RA., Dev Biol. March 15, 2009; 327 (2): 376-85.
Spatial and temporal expression of the Grainyhead-like transcription factor family during murine development. , Auden A., Gene Expr Patterns. October 1, 2006; 6 (8): 964-70.
Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome. , Dagenais SL., Gene Expr Patterns. October 1, 2004; 4 (6): 611-9.
Loss of the Sall3 gene leads to palate deficiency, abnormalities in cranial nerves, and perinatal lethality. , Parrish M., Mol Cell Biol. August 1, 2004; 24 (16): 7102-12.
Transcriptional regulation of the cardiac-specific MLC2 gene during Xenopus embryonic development. , Latinkic BV ., Development. February 1, 2004; 131 (3): 669-79.
Tissue and cellular localization of a novel polycystic kidney disease-like gene product, polycystin-L. , Basora N., J Am Soc Nephrol. February 1, 2002; 13 (2): 293-301.
Selective expression of the large neutral amino acid transporter at the blood- brain barrier. , Boado RJ., Proc Natl Acad Sci U S A. October 12, 1999; 96 (21): 12079-84.
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. , Pineda M., J Biol Chem. July 9, 1999; 274 (28): 19738-44.